Analysen zu BAT PLC (British American Tobacco)
| 11.03.24 | BAT Buy | Jefferies & Company Inc. | |
| 21.02.24 | BAT Neutral | UBS AG | |
| 19.02.24 | BAT Overweight | Barclays Capital | |
| 19.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 15.02.24 | BAT Buy | Deutsche Bank AG | |
| 13.02.24 | BAT Neutral | UBS AG | |
| 12.02.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 12.02.24 | BAT Neutral | Goldman Sachs Group Inc. | |
| 08.02.24 | BAT Neutral | UBS AG | |
| 08.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 08.02.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 07.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 05.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 30.01.24 | BAT Neutral | UBS AG | |
| 29.01.24 | BAT Neutral | UBS AG | |
| 23.01.24 | BAT Neutral | UBS AG | |
| 10.01.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 12.12.23 | BAT Sector Perform | RBC Capital Markets | |
| 11.12.23 | BAT Buy | Jefferies & Company Inc. | |
| 08.12.23 | BAT Buy | UBS AG | |
| 08.12.23 | BAT Sector Perform | RBC Capital Markets | |
| 07.12.23 | BAT Buy | Deutsche Bank AG | |
| 07.12.23 | BAT Overweight | Barclays Capital | |
| 07.12.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 06.12.23 | BAT Overweight | Barclays Capital | |
| 06.12.23 | BAT Buy | Jefferies & Company Inc. | |
| 06.12.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 06.12.23 | BAT Buy | Jefferies & Company Inc. | |
| 06.12.23 | BAT Sector Perform | RBC Capital Markets | |
| 06.12.23 | BAT Buy | UBS AG | |
| 05.12.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 01.12.23 | BAT Buy | Jefferies & Company Inc. | |
| 01.12.23 | BAT Overweight | Barclays Capital | |
| 29.11.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 23.11.23 | BAT Sector Perform | RBC Capital Markets | |
| 17.11.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 02.11.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 13.10.23 | BAT Buy | Jefferies & Company Inc. | |
| 13.10.23 | BAT Buy | UBS AG | |
| 13.10.23 | BAT Buy | Jefferies & Company Inc. | |
| 05.10.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 13.09.23 | BAT Buy | UBS AG | |
| 29.08.23 | BAT Buy | UBS AG | |
| 22.08.23 | BAT Buy | Jefferies & Company Inc. | |
| 08.08.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 31.07.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 28.07.23 | BAT Overweight | Barclays Capital | |
| 28.07.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 27.07.23 | BAT Buy | UBS AG | |
| 27.07.23 | BAT Buy | Deutsche Bank AG |
Aktuelle Aktienanalysen
| 30.01.25 | ABB Underperform | Bernstein Research | |
| 30.01.25 | LVMH Moet Hennessy Louis Vuitton Outperform | Bernstein Research | |
| 30.01.25 | T-Mobile US Market-Perform | Bernstein Research | |
| 30.01.25 | Schneider Electric Outperform | Bernstein Research | |
| 30.01.25 | Beiersdorf Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.25 | Sartorius vz. Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | Adyen B.V. Parts Sociales Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | E.ON Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | Nordea Bank Abp Registered Shs Buy | UBS AG | |
| 30.01.25 | Volvo AB Neutral | UBS AG | |
| 30.01.25 | ASML NV Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | T-Mobile US Buy | UBS AG | |
| 30.01.25 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | EssilorLuxottica Neutral | UBS AG | |
| 30.01.25 | GSK Neutral | UBS AG | |
| 30.01.25 | Knorr-Bremse Buy | UBS AG | |
| 30.01.25 | SAP Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | T-Mobile US Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Continental Buy | UBS AG | |
| 30.01.25 | AstraZeneca Neutral | UBS AG | |
| 30.01.25 | Hapag-Lloyd Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | DWS Group Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Assicurazioni Generali Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | DWS Group Neutral | UBS AG | |
| 30.01.25 | ABB Neutral | UBS AG | |
| 30.01.25 | Roche Neutral | UBS AG | |
| 30.01.25 | Nokia Neutral | UBS AG | |
| 30.01.25 | Sanofi Buy | UBS AG | |
| 30.01.25 | Nordea Bank Abp Registered Shs Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Tesla Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | Hennes & Mauritz AB Buy | UBS AG | |
| 30.01.25 | IBM Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | Meta Platforms Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | Tesla Sell | UBS AG | |
| 30.01.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | DWS Group Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | Henkel vz. Hold | Jefferies & Company Inc. | |
| 30.01.25 | Sartorius vz. Hold | Jefferies & Company Inc. | |
| 30.01.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 30.01.25 | Shell Outperform | RBC Capital Markets | |
| 30.01.25 | ASML NV Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | ASML NV Neutral | UBS AG | |
| 30.01.25 | STMicroelectronics Buy | UBS AG | |
| 30.01.25 | STMicroelectronics Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | ABB Neutral | Goldman Sachs Group Inc. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.